Valproic acid Completed Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT003391965-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
NCT00867672Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia